Literature DB >> 24686370

Lower NIH stroke scale scores are required to accurately predict a good prognosis in posterior circulation stroke.

Violiza Inoa1, Abraham W Aron, Ilene Staff, Gilbert Fortunato, Lauren H Sansing.   

Abstract

BACKGROUND: The NIH stroke scale (NIHSS) is an indispensable tool that aids in the determination of acute stroke prognosis and decision making. Patients with posterior circulation (PC) strokes often present with lower NIHSS scores, which may result in the withholding of thrombolytic treatment from these patients. However, whether these lower initial NIHSS scores predict better long-term prognoses is uncertain. We aimed to assess the utility of the NIHSS at presentation for predicting the functional outcome at 3 months in anterior circulation (AC) versus PC strokes.
METHODS: This was a retrospective analysis of a large prospectively collected database of adults with acute ischemic stroke. Univariate and multivariate analyses were conducted to identify factors associated with outcome. Additional analyses were performed to determine the receiver operating characteristic (ROC) curves for NIHSS scores and outcomes in AC and PC infarctions. Both the optimal cutoffs for maximal diagnostic accuracy and the cutoffs to obtain >80% sensitivity for poor outcomes were determined in AC and PC strokes.
RESULTS: The analysis included 1,197 patients with AC stroke and 372 with PC stroke. The median initial NIHSS score for patients with AC strokes was 7 and for PC strokes it was 2. The majority (71%) of PC stroke patients had baseline NIHSS scores ≤4, and 15% of these 'minor' stroke patients had a poor outcome at 3 months. ROC analysis identified that the optimal NIHSS cutoff for outcome prediction after infarction in the AC was 8 and for infarction in the PC it was 4. To achieve >80% sensitivity for detecting patients with a subsequent poor outcome, the NIHSS cutoff for infarctions in the AC was 4 and for infarctions in the PC it was 2.
CONCLUSION: The NIHSS cutoff that most accurately predicts outcomes is 4 points higher in AC compared to PC infarctions. There is potential for poor outcomes in patients with PC strokes and low NIHSS scores, suggesting that thrombolytic treatment should not be withheld from these patients based solely on the NIHSS.
© 2014 S. Karger AG, Basel. © 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24686370      PMCID: PMC4956480          DOI: 10.1159/000358869

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  17 in total

1.  Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke.

Authors:  Pooja Khatri; Mark R Conaway; Karen C Johnston
Journal:  Stroke       Date:  2011-11-03       Impact factor: 7.914

2.  Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke.

Authors:  Eric E Smith; Abdul R Abdullah; Iva Petkovska; Eric Rosenthal; Walter J Koroshetz; Lee H Schwamm
Journal:  Stroke       Date:  2005-10-06       Impact factor: 7.914

3.  Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity.

Authors:  Brett C Meyer; Thomas M Hemmen; Christy M Jackson; Patrick D Lyden
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

4.  Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS network.

Authors:  Joshua Z Willey; Pooja Khatri; Jane C Khoury; José G Merino; Andria L Ford; Natalia S Rost; Nicole R Gonzales; Latisha K Ali; Brett C Meyer; Joseph P Broderick
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-12-15       Impact factor: 2.136

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study.

Authors:  Maurizio Paciaroni; Giancarlo Agnelli; Francesco Corea; Walter Ageno; Andrea Alberti; Alessia Lanari; Valeria Caso; Sara Micheli; Luca Bertolani; Michele Venti; Francesco Palmerini; Sergio Biagini; Giancarlo Comi; Paolo Previdi; Giorgio Silvestrelli
Journal:  Stroke       Date:  2008-06-05       Impact factor: 7.914

7.  Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes.

Authors:  S Sato; K Toyoda; T Uehara; N Toratani; C Yokota; H Moriwaki; H Naritomi; K Minematsu
Journal:  Neurology       Date:  2008-04-23       Impact factor: 9.910

8.  Factors related to the initial stroke severity of posterior circulation ischemic stroke.

Authors:  Seo Hyun Kim; Ji-Yong Lee; Do Han Kim; Jee Hyun Ham; Young Ki Song; Eun Ju Lim; Chan Ik Park; Sei-Jin Chang; Sung-Soo Lee
Journal:  Cerebrovasc Dis       Date:  2013-07-30       Impact factor: 2.762

9.  The modified National Institutes of Health Stroke Scale: its time has come.

Authors:  B C Meyer; P D Lyden
Journal:  Int J Stroke       Date:  2009-08       Impact factor: 5.266

10.  A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity.

Authors:  P D Lyden; M Lu; S R Levine; T G Brott; J Broderick
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

View more
  17 in total

1.  An NIHSS of 0 and a Very Disabling Stroke.

Authors:  Sherri A Braksick; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

2.  Glasgow Coma Scale on Presentation Predicts Outcome in Endovascular Treatment for Acute Posterior Large-Vessel Occlusion.

Authors:  A H Chiu; D A Hince; W McAuliffe
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-26       Impact factor: 3.825

Review 3.  [Prediction in cerebrovascular diseases].

Authors:  G F Hamann
Journal:  Nervenarzt       Date:  2014-10       Impact factor: 1.214

Review 4.  The use of dual antiplatelet therapy for ischemic cerebrovascular events.

Authors:  Francesco Mele; Claudia Gendarini; Leonardo Pantoni
Journal:  Neurol Sci       Date:  2022-09-17       Impact factor: 3.830

5.  Time to Presentation Is Associated with Clinical Outcome in Hemispheric Stroke Patients Deemed Ineligible for Recanalization Therapy.

Authors:  Yunis Mayasi; Johanna Helenius; Richard P Goddeau; Majaz Moonis; Nils Henninger
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-06-14       Impact factor: 2.136

6.  Red cell distribution width and neurological scoring systems in acute stroke patients.

Authors:  Hasan Kara; Selim Degirmenci; Aysegul Bayir; Ahmet Ak; Murat Akinci; Ali Dogru; Fikret Akyurek; Seyit Ali Kayis
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-18       Impact factor: 2.570

7.  Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society.

Authors:  Katja E Wartenberg; David Y Hwang; Karl Georg Haeusler; Susanne Muehlschlegel; Oliver W Sakowitz; Dominik Madžar; Hajo M Hamer; Alejandro A Rabinstein; David M Greer; J Claude Hemphill; Juergen Meixensberger; Panayiotis N Varelas
Journal:  Neurocrit Care       Date:  2019-10       Impact factor: 3.210

8.  Relation of infarction location and volume to vertigo in vertebrobasilar stroke.

Authors:  Ahmed Mohamed Elhfnawy; Mervat Abd El-Raouf; Jens Volkmann; Felix Fluri; Doaa Elsalamawy
Journal:  Brain Behav       Date:  2020-02-05       Impact factor: 2.708

9.  Prehospital and intra-hospital time delays in posterior circulation stroke: results from the Austrian Stroke Unit Registry.

Authors:  Peter Sommer; Leonhard Seyfang; Alexandra Posekany; Julia Ferrari; Wilfried Lang; Elisabeth Fertl; Wolfgang Serles; Thomas Töll; Stefan Kiechl; Stefan Greisenegger
Journal:  J Neurol       Date:  2016-11-07       Impact factor: 4.849

10.  Evaluation of Ataxia in Mild Ischemic Stroke Patients Using the Scale for the Assessment and Rating of Ataxia (SARA).

Authors:  Sung Won Choi; Nami Han; Sang Hoon Jung; Hyun Dong Kim; Mi Ja Eom; Hyun Woo Bae
Journal:  Ann Rehabil Med       Date:  2018-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.